论文部分内容阅读
目的探讨瘤体内尿素注射联合手术切除治疗足部海绵状血管瘤的临床效果。方法 62例足部海绵状血管瘤患者均行瘤体尿素注射+手术切除治疗,术后随访24~48个月,观察局部症状、关节活动改善情况及复发率。结果 62例中行一期根治性切除术41例,分期根治性手术17例,减瘤手术4例,同期行肌腱延长/黏连松解术11例;术后局部疼痛缓解率为80.95%(17/21),关节活动度改善率为72.73%(8/11)。术后6~12个月复发5例(一期根治性切除术3例,分期根治性手术2例),复发率为8.06%,术后>12~48个月无新增复发患者。结论瘤体内尿素注射后行手术治疗可降低手术难度及风险,治疗足部海绵状血管瘤疗效确切。
Objective To investigate the clinical effect of tumor injection combined with surgical resection on cavernous hemangioma in the foot. Methods Totally 62 cases of cavernous hemangioma of the foot were treated with tumor injection of urea and surgical resection. The patients were followed up for 24-48 months. The local symptoms, the improvement of joint activities and the recurrence rate were observed. Results In the 62 cases of radical mastectomy, 41 cases were treated by radical mastectomy, 17 cases were treated by staging operation, 4 cases were treated by reduction surgery, and 11 cases were treated with tendon lengthening / adhesion lysis in the same period. The local pain relief rate was 80.95% (17 / 21), and the improvement rate of joint activity was 72.73% (8/11). Five patients relapsed 6 to 12 months after operation (3 cases of primary radical resection and 2 cases of radical surgery). The recurrence rate was 8.06%. No recurrence was found after 12 to 48 months. Conclusion Surgical treatment of urethral injection of tumor can reduce the difficulty and risk of operation, and the curative effect of treating cavernous hemangioma in foot is definite.